Clinical Trial Update: Safety and Tolerability of Metronidazole Gel 1.3% [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating safety and tolerability of metronidazole gel 1.3% for vaginal bacterial vaginosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Vaginosis

Drugs mentioned

• Metronidazole gel 1.3% (metronidazole)

Snippet

Sponsor: Insud Pharma | Conditions: Vaginosis, Bacterial | Phase 4 | Status: COMPLETED